Pulmatrix, Inc. (PULM) financial statements (2021 and earlier)

Company profile

Business Address 99 HAYDEN AVENUE
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments233441910
Cash and cash equivalents233441910
Receivables7 000 
Prepaid expense000000
Deferred costs00001 
Other current assets     0
Other undisclosed current assets000000
Total current assets:313452011
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment001110
Intangible assets, net (including goodwill)411111123 
Goodwill411111116 
Intangible assets, net (excluding goodwill)    8 
Restricted cash and investments00000 
Total noncurrent assets:5111212240
TOTAL ASSETS:361516174511
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:333231
Accounts payable11011 
Accrued liabilities322110
Employee-related liabilities     0
Other undisclosed accounts payable and accrued liabilities     0
Deferred revenue13
Debt1 331 
Total current liabilities:1736541
Noncurrent Liabilities
Long-term debt and lease obligation   36 
Long-term debt, excluding current maturities   36 
Liabilities, other than long-term debt8 003 
Deferred revenue8
Deferred tax liabilities, net   3 
Derivative instruments and hedges, liabilities  000 
Total noncurrent liabilities:8 039 
Total liabilities:25368121
Stockholders' equity
Stockholders' equity attributable to parent11121093310
Common stock0 0000
Additional paid in capital22620618416516120
Accumulated deficit(215)(195)(174)(156)(128)(10)
Total stockholders' equity:11121093310
TOTAL LIABILITIES AND EQUITY:361516174511

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
Gross profit:80011 
Operating expenses(29)(20)(18)(26)(24)(7)
Operating loss:(21)(20)(17)(25)(23)(7)
Nonoperating income (expense)0(0)0(0)(0)0
Investment income, nonoperating0    0
Other nonoperating income (expense)(0)00(0)(0) 
Interest and debt expense (0)(1)(1)(1) 
Loss from continuing operations before equity method investments, income taxes:(21)(21)(18)(26)(24)(7)
Other undisclosed income (loss) from continuing operations before income taxes  0(5)  
Loss from continuing operations before income taxes:(21)(21)(18)(31)(24)(7)
Income tax benefit   3 4
Loss before gain (loss) on sale of properties:(21)(21)(18)(28)(24)(3)
Other undisclosed net income 0    
Net loss:(21)(21)(18)(28)(24)(3)
Other undisclosed net loss attributable to parent    (2)(4)
Net loss available to common stockholders, diluted:(21)(21)(18)(28)(26)(7)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
Net loss:(21)(21)(18)(28)(24)(3)
Comprehensive loss, net of tax, attributable to parent:(21)(21)(18)(28)(24)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: